Traws Pharma, Inc.
TRAW
$0.54
-$0.01-2.26%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.57M | -19.43M | 9.17M | -13.31M | -17.82M |
| Total Depreciation and Amortization | 147.00K | 104.00K | 61.00K | 19.00K | 6.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.95M | 1.31M | -25.84M | -1.48M | -1.28M |
| Change in Net Operating Assets | 2.62M | 2.69M | -1.58M | -4.69M | -7.84M |
| Cash from Operations | -16.85M | -15.32M | -18.19M | -19.47M | -26.93M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.59M | -2.59M | -2.59M | -2.59M | -- |
| Cash from Investing | -2.59M | -2.59M | -2.59M | -2.59M | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.23M | 7.37M | 5.61M | 23.49M | 23.37M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.85M | -2.28M | -2.40M | -465.00K | -287.00K |
| Cash from Financing | 11.38M | 5.09M | 3.20M | 23.02M | 23.09M |
| Foreign Exchange rate Adjustments | -14.00K | 17.00K | 48.00K | 39.00K | 42.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.07M | -12.80M | -17.52M | 1.01M | -3.81M |